Literature DB >> 16979030

Pathology of inflammatory native valvular heart disease.

John P Veinot1.   

Abstract

Rheumatic disease is an important cause of inflammatory native heart valve disease. However, with increased understanding of the pathoetiology of valve disease and valve injury, it is evident that inflammation may play a role in many valve disorders. We are only beginning to understand these complex processes. With increasing knowledge that many of these processes are active, there may be opportunity for intervention or even prevention.

Entities:  

Mesh:

Year:  2006        PMID: 16979030     DOI: 10.1016/j.carpath.2006.04.007

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  11 in total

Review 1.  Cellular mechanisms in mitral valve disease.

Authors:  Kareem Salhiyyah; Magdi H Yacoub; Adrian H Chester
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

2.  Mitral valve geometry in paediatric rheumatic mitral regurgitation.

Authors:  Michael Yeong; Marcus Silbery; Kirsten Finucane; Nigel J Wilson; Thomas L Gentles
Journal:  Pediatr Cardiol       Date:  2015-01-06       Impact factor: 1.655

Review 3.  Pathology of the Aortic Valve: Aortic Valve Stenosis/Aortic Regurgitation.

Authors:  Gregory A Fishbein; Michael C Fishbein
Journal:  Curr Cardiol Rep       Date:  2019-07-05       Impact factor: 2.931

4.  Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly.

Authors:  Gretchen J Mahler; Jonathan T Butcher
Journal:  Int J Inflam       Date:  2011-07-18

5.  Risk of valvular heart disease after treatment for Hodgkin lymphoma.

Authors:  David J Cutter; Michael Schaapveld; Sarah C Darby; Michael Hauptmann; Frederika A van Nimwegen; Augustinus D G Krol; Cecile P M Janus; Flora E van Leeuwen; Berthe M P Aleman
Journal:  J Natl Cancer Inst       Date:  2015-02-23       Impact factor: 13.506

6.  Analysis of immunostaining and western blotting of endothelin 1 and its receptors in mitral stenosis.

Authors:  Sydney Correia Leão; Michael R Dashwood; Mateus Santana de Andrade; Nicolas Nascimento Santos; Olivia Regina Lins Leal Teles; Williasmin Batista de Souza; Tania Maria de Andrade Rodrigues
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

7.  ANP and BNP plasma levels in patients with rheumatic mitral stenosis after percutaneous balloon mitral valvuloplasty.

Authors:  Łukasz Mazurkiewicz; Witold Rużyłło; Zbigniew Chmielak; Ewa Opalińska-Ciszek; Jadwiga Janas; Piotr Hoffman; Tomasz Hryniewiecki; Jacek Grzybowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

8.  IL-10 and ET-1 as biomarkers of rheumatic valve disease.

Authors:  Sydney Correia Leão; Maria Regina Menezes Lima; Hertaline Menezes do Nascimento; Shirlei Octacilio-Silva; Tania Maria de Andrade Rodrigues
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Jan-Mar

9.  CC-chemokine receptor 7 and its ligand CCL19 promote mitral valve interstitial cell migration and repair.

Authors:  Xiaozhi Wang; Liang Wang; Liping Miao; Rong Zhao; Yanhu Wu; Xiangqing Kong
Journal:  J Biomed Res       Date:  2015-09-09

Review 10.  Oscillatory fluid-induced mechanobiology in heart valves with parallels to the vasculature.

Authors:  Chia-Pei Denise Hsu; Joshua D Hutcheson; Sharan Ramaswamy
Journal:  Vasc Biol       Date:  2020-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.